RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and ...

The development of new medication by biotech and pharmaceutical companies, from target identification to marketing approval, is a time-consuming process with timelines extending to 12 years or more.

The government held a consultative meeting with private sector stakeholders on Thursday to promote the use of AI in drug development in response to the intensifying global competition in the ...

SEOUL, May 15 (Yonhap) -- The government held a consultative meeting with private sector stakeholders Thursday to promote the use of artificial intelligence (AI) in drug development in response to the ...